Literature DB >> 956804

Skin conductance responding/nonresponding and pupiliometrics in chronic schizophrenia. A confirmation of Gruzelier and Venables.

T Patterson.   

Abstract

In a number of reports, Gruzelier and Venables have demonstrated that about 50% of the schizophrenic population do not show the skin conductance orienting response (S.C.O.R.), while those that do respond, do not show normal habituation. Zahn (Orienting response in schizophrenics. J. Nerv. Ment. Dis., 162: 195-199, 1976) has questioned the bimodality of the S.C.O.R. in schizophrenia and suggests that responding/nonresponding could well be due to differential effects of phenothiazine medication. In two experiments (with equally medicated patients), in two different hospitals, the present report confirms the finding of a large proportion of nonresponding in schizophrenia but also suggests that both normal and nonhabituation are seen within schizophrenics and normals. Differential pupillary dilation and constriction parameters are seen in responders and nonresponders although both of these patient groups show tachycardia (the most usual effect of phenothiazines) in comparison to the normal group. The results do not fit easily into the differential effect of phenothiazines hypothesis proposed by Zahn.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956804     DOI: 10.1097/00005053-197609000-00008

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Bilateral skin conductance and the pupillary light-dark reflex: manipulation by chlorpromazine, haloperidol, scopolamine, and placebo.

Authors:  T Patterson; P H Venables
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

2.  Eye movement research with schizophrenic patients and normal controls using corneal reflection-pupil center measurement.

Authors:  W Gaebel; G Ulrich; K Frick
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

Review 3.  A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia.

Authors:  Costa Vakalopoulos
Journal:  Ment Illn       Date:  2010-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.